Companies / CUE Biopharma
CUE Biopharma
Somerville, United States
CUE Biopharma is a clinical-stage biopharmaceutical company focused on advancing a robust portfolio of therapies aimed at enabling functional cures across allergic and autoimmune diseases.
CUE Biopharma, based in Somerville, United States, has 1 investor on file, among them Vivo Capital. Its site was last checked 20 Nov 2026: site answers.
SEC Form D filings
6 filingsFiled by Cue Biopharma, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
In the news
3 headlines naming CUE BiopharmaEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
More from Vivo Capital
83 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (99%), Robotics & Hardware (4%), Food & Agriculture (1%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get CUE Biopharma and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Vivo Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/cuebiopharma.com/investors
# also
GET /v1/companies/cuebiopharma.com
GET /v1/companies/cuebiopharma.com/news